Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Canadian launch set for skin cholesterol test

Oct. 15, 2012

Navidea provides update on Lymphoseek NDA

Oct. 11, 2012

First OTC HIV test now available in U.S.

Oct. 10, 2012

Amarantus and Rainbow BioSciences form joint venture for NuroPro test

Oct. 10, 2012

Phase II trial begins for molecular imaging drug for prostate cancer

Oct. 1, 2012

Navidea receives complete response letter from FDA regarding Lymphoseek NDA

Sep. 27, 2012

Navidea Biopharmaceuticals receives NIH grant to develop RIGS agent

Sep. 25, 2012

Phase II study of PET imaging agent for Alzheimer's disease begins enrollment

Sep. 19, 2012

Life Technologies and Bristol-Myers Squibb collaborate on companion diagnostics

Sep. 18, 2012

RepliGen withdraws MAA for SecreFlo

Sep. 17, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...